1. Home
  2. CARS vs PHVS Comparison

CARS vs PHVS Comparison

Compare CARS & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cars.com Inc.

CARS

Cars.com Inc.

HOLD

Current Price

$10.05

Market Cap

476.1M

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$29.28

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARS
PHVS
Founded
1998
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
476.1M
1.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CARS
PHVS
Price
$10.05
$29.28
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$16.00
$41.82
AVG Volume (30 Days)
809.0K
393.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$723,239,000.00
N/A
Revenue This Year
$3.03
N/A
Revenue Next Year
$2.57
N/A
P/E Ratio
$125.44
N/A
Revenue Growth
0.57
N/A
52 Week Low
$7.40
$15.93
52 Week High
$13.97
$33.33

Technical Indicators

Market Signals
Indicator
CARS
PHVS
Relative Strength Index (RSI) 47.07 49.32
Support Level $7.64 $24.73
Resistance Level $11.53 $31.14
Average True Range (ATR) 0.48 1.55
MACD -0.16 -0.17
Stochastic Oscillator 20.41 22.20

Price Performance

Historical Comparison
CARS
PHVS

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: